Tirofiban Hydrochloride

FDA Drug Profile — Tirofiban Hydrochloride

Tirofiban Hydrochloride is listed in the FDA National Drug Code directory with 6 NDC codes, marketed under brand name including Tirofiban Hydrochloride. Available dosage forms: injection, solution, injection, powder.

Drug details

Generic Name
Tirofiban Hydrochloride
Brand Names
Tirofiban Hydrochloride
Application Number
ANDA206888
Sponsor
Sagent Pharmaceuticals
NDC Codes
6
Dosage Forms
INJECTION, SOLUTION, INJECTION, POWDER
Routes
INTRAVENOUS
Active Ingredients
TIROFIBAN HYDROCHLORIDE

Indications and Usage

1 INDICATIONS AND USAGE Tirofiban Hydrochloride Injection is indicated to reduce the rate of thrombotic cardiovascular events (combined endpoint of death, myocardial infarction, or refractory ischemia/repeat cardiac procedure) in patients with non-ST elevation acute coronary syndrome (NSTE-ACS). Tirofiban Hydrochloride Injection is a platelet aggregation inhibitor indicated to reduce the rate of thrombotic cardiovascular events (combined endpoint of death, myocardial infarction, or refractory ischemia/repeat cardiac procedure) in patients with non-ST elevation acute coronary syndrome (NSTE-ACS). ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.